Skip to content

Efficacy of recombinant HVT + IBD + H5 vaccine against novel variant infectious bursal disease, A2dB1b, in broiler and SPF chickens.

Sep 2026 · Avian Pathology · pp. 1-26 · 0 citations · 21 references
Medicine

TL;DR

Higher protective efficacy of rHVT’s+ IBD’s+ H5 hatchery vaccination against Egyptian nVArIBDV, A2dB1b is demonstrated, especially in the broiler chickens G4 that had specific MDA.

Abstract

The increasing prevalence of antigenic variations and genetic reassortments of Infectious Bursal Disease virus (IBDV) across various global regions, causing subclinical infections, poses a significant threat to the poultry industry, leading to substantial losses. In the current study, the protective efficacy of recombinant trivalent vaccine rHVT + IBD + H5, administered once at 1-day old (DO) in the hatchery was assessed against challenge with the most recent circulating novel variant IBD (nVarIBDV), A2dB1b, Egyptian isolate (IBD/EGY/F1335/2023) in commercial broiler, and specific pathogen free (SPF) chickens at 28 DO. A total of 210, commercial broilers and 120 SPF chicks, housed at BSL-3 conditions, were divided into 11 equal groups (Broilers, G1-G7, and SPF G8-G11, n = 30/group). The bursa/body weight ratio (BBR) and bursa/body weight index (BBI) scores calculated at 4-, 7-, 10-, and 14-days post-infection (DPC) revealed significantly higher scores in the vaccinated challenged broiler groups (especially G4) and in the vaccinated challenged SPF group (G8) as compared to their control non-vaccinated challenged groups, G2, G5 and G9, respectively. Additionally, the histopathological and immunohistochemical examinations indicated significantly higher protection in the vaccinated-challenged broilers (G1 and G4) and SPF (G8) groups in comparison to their controls. Overall, this study demonstrated higher protective efficacy of rHVT + IBD + H5 hatchery vaccination against Egyptian nVArIBDV, A2dB1b, especially in the broiler chickens G4 that had specific MDA.

View source

Similar papers

Open access Sep 2026

A recombinant Newcastle disease virus-vectored multi-epitope vaccine confers protection against QX-like infectious bronchitis virus in chickens

Protection was accompanied by an increased frequency of splenic CD3 + CD8 + T cells, particularly after booster immunization, suggesting a role for cellular immunity alongside neutralizing antibodies.

Fei Wang, Jia-Nan Xie, Guo-Yuan Wen et al. · 0 citations
Open access Sep 2026

Recombinant GI-19 infectious bronchitis virus induction of humoral immunosuppression with reduced HI antibody response following Newcastle disease virus vaccination and bursal cell apoptosis

Pathological changes and viral presence in the bursa of Fabricius (BF) have been reported, but the immunosuppression of infectious bronchitis virus (IBV) remains poorly characterized. Here, we systematically evaluated the pathogenicity of two GI-19 lineage IBV isolates, CK/CH/FJ-B3/2023 (bursal origin) and CK/CH/FJ-T5/...

Chen-Yan Wang, Wei-Jia Zhang, Bo Hou · 0 citations
Open access Sep 2026

Recombinant B87 and HLJ0504 VP2 Vaccines Protect Chickens Against Infectious Bursal Disease

Infectious bursal disease virus (IBDV) causes immunosuppression and bursal damage in chickens, and safer recombinant vaccines that provide durable protection are needed. This study compared the antigenicity, immunogenicity, protective efficacy, safety and antibody persistence of unpurified VP2 preparations and purified...

Tayyab Ali Asif, Peng Chen, Jia-Hao Li et al. · 0 citations
Open access Sep 2026

Immunization Efficacy of a Commercialized Inactivated Mycoplasma bovis (Strain HM) Vaccine in Calves at a Large-Scale Dairy Farm in Yancheng, Jiangsu Province

Simple Summary Bovine Respiratory Disease (BRD) caused by Mycoplasma bovis (M. bovis) infection results in substantial economic losses to the livestock industry. Therefore, it is urgent to develop effective vaccines to prevent and control M. bovis-positive clinical BRD. To systematically evaluate the efficacy of a comm...

Ying-Jian Li, Rui-Hua Zhang, Yi-Quan Jin et al. · 0 citations
Review Sep 2026

Molecular Epidemiology, Genogroup Classification and Diversity of Infectious Bursal Disease Virus.

The review highlights a nomenclature conflict regarding the A9 designation, which currently refers to both attenuated strain and pathogenic variant from Portugal, and phylogenetic analysis reveals that the evolution of segment B (VP1) is independent of segment A (VP2), necessitating a bi-segmental approach.

H. B. Aliyu, A. A. Raji, J. Abu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.